CN106012513A - Antibacterial finishing method of chitosan derivative of medical fabric for surgeries - Google Patents
Antibacterial finishing method of chitosan derivative of medical fabric for surgeries Download PDFInfo
- Publication number
- CN106012513A CN106012513A CN201610502434.0A CN201610502434A CN106012513A CN 106012513 A CN106012513 A CN 106012513A CN 201610502434 A CN201610502434 A CN 201610502434A CN 106012513 A CN106012513 A CN 106012513A
- Authority
- CN
- China
- Prior art keywords
- parts
- agent
- acid
- fabric
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/10—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
- D06M13/224—Esters of carboxylic acids; Esters of carbonic acid
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/10—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing oxygen
- D06M13/224—Esters of carboxylic acids; Esters of carbonic acid
- D06M13/2243—Mono-, di-, or triglycerides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/01—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with natural macromolecular compounds or derivatives thereof
- D06M15/03—Polysaccharides or derivatives thereof
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/263—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acids; Salts or esters thereof
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
- D06P1/39—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using acid dyes
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
The invention provides an antibacterial finishing method of a chitosan derivative of a medical fabric for surgeries. The method comprises the steps of impregnation in an acid dye working solution and impregnation in a chitosan derivative antibacterial finishing agent, wherein the acid dye working solution comprises the following components by concentration: 2-7g/L of acid dye, 5-8g/L of acetic acid, 0.3-1g/L of levelling agent and 3-5g/L of fixing agent; and the pH value and take-up of the acid dye working solution are respectively 4-6 and 100%. The antibacterial finishing method has the beneficial effects that the antibacterial rate of a prepared biological antibacterial fabric can be still more than 99% after the biological antibacterial fabric is washed 50 times with high temperature water; tests show that the 24h average inhibition rate of the antibacterial fabric toward staphylococcus aureus and escherichia coli is 100%; and the 24h average inhibition rate of the antibacterial fabric toward candida albicans is 99.85%. The prepared fabric has good air permeability and moisture permeability besides a good antibacterial function.
Description
Technical field
The present invention relates to the antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation, specifically a kind of
Novel environmentally-friendly biological antibacterial finishing agent, in the application in Medical face fabric field, belongs to Novel medical textile garment field.
Background technology
Along with functional textile continuous expansion of range of application in the range for the treatment of, people to the demand of medical textile from
Single use, dress, develop to more multi-functional aspect now, and wish that identical product has different functions and advantage concurrently, special
It not the fabric used in operation process, after manually sterilization bacteria removing, the most directly use, or pass through
Increase chemistry antibacterial on fabric so that it is obtain antibacterial effect, so likely can be invisible during use cause two
Secondary pollution, damages patients ' lives health.So now medical operation fabric being had higher requirement.People are
Reduce generations of these injuries, developed from monistic medical operation fabric with regard to this, then to artificial chemical composition of adding
Functional medical operation fabric, biological functional fabric till now.The appearance of Biofunctional fabric solves above asking
The weak point of topic, decreases patient's secondary pollution in operation process, promotes the healing of wound, maintains the life of patient
Health, the functional product developing health carried now with biology is the direction that people make great efforts development.
Existing Medical face fabric yet suffers from following deficiency:
(1) Medical face fabric is one of important medium propagating pathogen, and the antibacterial on fabric, after hot wash, still
There is a large amount of antibacterial；
(2) the moisture-penetrable ventilated poor-performing of Medical face fabric；
(3) mosquito of hospital, acarid etc. are propagated virus, antibacterial, more increase the probability of cross infection, of the prior art
Material, the effect of mosquito dispersing and acarid is poor.
Summary of the invention
The problem to be solved in the present invention is for above not enough, it is provided that the chitosan derivatives of a kind of Medical face fabric of performing the operation
Antibiotic finishing method, to realize following goal of the invention:
(1) present invention fabric after antibiotic finish, has good antibacterial functions；
(2) present invention fabric after antibiotic finish, has good ventilative, water vapour permeability；
(3) present invention fabric after antibiotic finish is high to the scattering ratio of mosquito, acarid.
For solving above-mentioned technical problem, the technical scheme that the present invention takes is as follows:
A kind of antibiotic finishing method of the chitosan derivatives of Medical face fabric of performing the operation, it is characterised in that: include
Dipping acid stain working solution, dipping chitosan derivative antibacterial finishing agent step.
The following is and the further of technique scheme is improved:
Described acid stain working solution, the concentration of each composition is: acid stain 2-7g/L, acetic acid 5-8 g/L, levelling agent 0.3-1
G/L, color fixing agent 3-5 g/L；Described acid stain working solution, pH 4-6, liquid carrying rate 100%.
Described dipping acid stain working solution, dipping temperature is 45-60 DEG C.
Described acid stain working solution, the concentration of each composition is, preferably acid stain 2g/L, acetic acid 5 g/L, levelling agent
0.5 g/L, color fixing agent 5 g/L.
Described chitosan derivative antibacterial finishing agent, including antibacterial finishing agent O-HTCCS 0.5-5g/L, cross-linking agent 4-
20g/L, catalyst 6-9g/L, penetrating agent 2-5g/L.
Described dipping chitosan derivative antibacterial finishing agent, bath raio 1:20.
Described cross-linking agent, model is DTF-31；Described catalyst, model is CQL-5；Described penetrating agent, model is JFC.
Described dipping chitosan derivative antibacterial finishing agent, detailed process is: first impregnated crosslinked dose and catalyst, two leachings two
Roll, liquid carrying rate 100%, after 80 DEG C dry 3 minutes, impregnate penetrating agent, liquid carrying rate 100%, then dipping antibacterial finishing agent O-
HTCCS, two leachings two roll, liquid carrying rate 100%, after 80 DEG C dry 3 minutes, 105 DEG C of preliminary drying 2min, 120-160 DEG C bake 1-3min,
Washing, 80 DEG C of drying 3min.
Described acid stain working solution, formula is acid stain 4 g/L, acetic acid 2 g/L, auxiliary agent 3g/L；Described auxiliary agent, with
Weight portion meter, including following components: 1-propyl group phosphoric acid cyclic anhydride 6 parts, caprolactam 7 parts, tea polyphenols 4 parts, saponin 3 parts, clove tree
2 parts of phenol, trioctyl phosphate 3 parts, resin acid calcium 5 parts, linoleic acid 6 parts, Oleum Folium Artemisiae Argyi 4 parts, alkylphenol polyoxyethylene 7 parts,
Dehydrated alcohol 4 parts.
Described chitosan derivative antibacterial finishing agent, including carboxymethyl chitosan 20 parts, Fructus Quisqualis extract 3 parts, Semen Torreyae
Extract 5 parts, Semen Coicis extract 4 parts, Concha Ostreae extract 6 parts, poly 5 parts, cyanuric acid three-glycidyl ester 3 parts,
Titanate esters 2 parts, Triammonium citrate 1 part, tea saponin 2 parts, ethyl sebacate 4 parts, penetrating agent OT 5 parts, cetene 3 parts, Cedrus deoclar (Roxb.) G. Don
Alcohol 2 parts, glyceryl monostearate 4 parts, dehydrated alcohol 8 parts；The concentration of described chitosan derivative antibacterial finishing agent is
50g/L。
By using this manufacturing process, the textile embryo cloth of employing, use two leachings two to roll process technique, dye printing and dyeing, dipping friendship
Connection agent, dipping chitosan derivatives finishing agent, then by drying and baking, be allowed to obtain permanent antibacterial effect.Reach to subtract
Lack patient's secondary pollution in operation process, promoted the effect of the healing of wound, can be widely used in and be applicable to medical treatment neck
The various products of territory operation medical textile.
The present invention uses above technical scheme, compared with prior art, has the advantages that
(1) in dipping antibiotic finish operation, dipping O-HTCCS chitosan derivatives finishing agent is used to process；After process
The biological antibiotic fabric prepared, still can reach more than 99% at antibiotic rate after 50 high-temperature water.The results showed, antibacterial
Fabric is 100% to the average inhibition of staphylococcus aureus effect 24h；Antibiotic facing material is average to escherichia coli effect 24h's
Suppression ratio is 100%；Antibiotic facing material is 99.85% to the average inhibition of Candida albicans effect 24h.
(2) fabric prepared by the present invention is except having good antibacterial functions, and has good ventilative, water vapour permeability, gram
Take what the functional medical operation fabric of artificial interpolation chemical composition brought shortcoming.Decrease patient in operation process
Secondary pollution, promotes the healing of wound, maintains the life and health of patient.
(3) fabric prepared by the present invention, also has the effect of anti-mite and mosquito proof, and rate of walking quickly and keeping away acarid reaches 96%, right
The rate of walking quickly and keeping away of mosquito reaches 97%.
Specific embodiment
Should be appreciated that preferred embodiment described herein is merely to illustrate and explains the present invention, be not used to limit this
Invention.
The antibiotic finishing method of the chitosan derivatives of 1 one kinds of Medical face fabrics of performing the operation of embodiment
After preparing grey cloth step, step of singing, grey cloth desizing, kiering, blanching step, dipping dye liquor step, enter back into leaching
The antibacterial finishing agent step of stain chitosan derivatives, subsequently into rolling step, specific as follows:
(1) grey cloth is prepared
Including grey cloth inspection, turn over cloth, margin to seam.
(2) singe
Fine hair on burning-off cloth cover, makes cloth cover bright and clean,
Prevent from, when dyeing, stamp, producing the defect of dyeing and stamp because fine hair exists；
Technique: enter cloth, bristle, singe, put out a fire, cropping, described in singe, temperature is 800-1000 DEG C.
(3) grey cloth desizing, kiering, bleaching
Padding to move back and boil drift working solution, use many leaching modes of rolling more, pick-up controls about 100%；Clot rotates and banks up, and banks up
During, fabric Polypropylence Sheet is sealed and wraps, prevent top layer from air-drying and slime spots occurs；Bank up 20 hours winters time, summer 15
Hour；
Described moving back boils drift working solution, including clean cotton enzyme 18g/L, refining agent 2g/L, penetrating agent 3.2g/L, 100% hydrogen peroxide 14.5g/
L。
(4) short steaming working solution is padded
Cold dome postpones first through 90 DEG C of hot water wash, then pads short steaming working solution, steam temperature more than 98 DEG C；
In described short steaming working solution, hydrogen peroxide concentration 8g/L, cold cotton enzyme 6g/L.
(5) cropping clot
Cropping car is not used to prevent fold.
(6) dipping acid stain working solution
Technological process is:
Dipping acid stain working solution → infrared preliminary drying → hot-air seasoning → hot melt drying → hot melt bake wash → soap →
Washing → dry.
Described acid stain working solution, formula is acid stain 2-7g/L, acetic acid 5-8 g/L, levelling agent 0.3-1 g/L,
Color fixing agent 3-5 g/L, pH 4-6, liquid carrying rate 100%；
Described dipping acid stain working solution, dipping temperature is 45-60 DEG C.
Described dyestuff working solution, acid stain 2g/L, acetic acid 5 g/L, levelling agent 0.5 g/L, color fixing agent 5 g/L, pH 4-
6, liquid carrying rate 100%, dipping temperature 45-60 DEG C, for preferred value, the performance index of product technologies prepared during this proportioning is optimum；
Described dyestuff, is produced by Shanghai Wan get Dye Co., Ltd；
Described color fixing agent, is produced by Beijing Jie Ershuan High Seience Technology Co., Ltd.；
Described acetic acid, is produced by Binzhou, Shandong auxiliary reagent factory；
Described levelling agent, model is peregal os-15, Binzhou, Shandong auxiliary reagent factory produce.
(7) dipping chitosan derivative antibacterial finishing agent step
Fabric uses dipping chitosan derivative antibacterial finishing agent process, then preliminary drying, dry, bake,
Described chitosan derivative antibacterial finishing agent, including antibacterial finishing agent O-HTCCS 0.5-5g/L cross-linking agent 4-20g/L, urges
Agent 6-9g/L, penetrating agent 2-5g/L, bath raio 1:20；
Described cross-linking agent, model is DTF-31；
Described catalyst, model is CQL-5；
Described penetrating agent, model is JFC；
Described chitosan derivative antibacterial finishing agent is that Switzerland's Clariant (Chinese) company limited produces；
Described cross-linking agent, penetrating agent and catalyst are that Beijing Jie Ershuan High Seience Technology Co., Ltd. produces；
The process of dip finishing agent is:
Fabric after dyeing → impregnated crosslinked dose and catalyst → bis-leaching two roll (liquid carrying rate 100%) → dry (80 DEG C, 3min) →
(liquid carrying rate 100%) → drying (80 is rolled in dipping penetrating agent (liquid carrying rate 100%) → dipping antibacterial finishing agent O-HTCCS → bis-leaching two
DEG C, 3min) → preliminary drying → bake (120-160 DEG C, 1-3min) → washing → drying (80 DEG C, 3min)；
Described preliminary drying, 105 DEG C of time about 2min of temperature；
Described baking temperature is 120-160 DEG C, time about 1-3min.
Through test of many times, polysaccharid derivative antibacterial finishing agent O-HTCCS, concentration is 5% (owf), cross-linking agent 15%
(owf), catalyst 7% (owf), penetrating agent 3% (owf), bath raio 1:20 is preferred value, and the prepared performance index of product technologies is
Excellent.
(8) rolling:
The fabric put in order is carried out clot, prepares nature, biological antibacterial operation Medical face fabric.
Polysaccharid derivative antibacterial medical fabric embodiment 1 prepared is after washing through 50 high-temperature water, and antibiotic rate is still
More than 99% can be reached, and there is good ventilative, poisture-penetrability.
The fabric of the embodiment of the present invention 1 preparation, moisture permeability is good, and measure wicking height is 153mm, and vapor transfer rate is 10200g
(m2, d), evaporation rate is 0.56g/h；Air permenbility reaches 9500g/m2/24hr。
Fabric after embodiment 2 embodiment of the present invention 1 antibiotic finish carries out antimicrobial properties test:
One, test procedure:
(1) by print with that photo is made 50mm × 50mm (about 0.5g) is standby.
(2) 18-24h agar slant culture 0.03mol/L phosphate buffer is washed down, prepares test organisms bacteria suspension,
Standby.
(3) uniformly inoculate 1.0ml bacteria suspension with sterilizing suction pipe respectively at print with on photo, after inoculation, put respectively
Enter in sterilizing bottle, each addition 100ml phosphate buffer, repeatedly extrude with suction pipe and vibrate, after dilution, laboring with tilt-pour process
Bacterium cultivates counting, detects the bacterium number of its " 0 " time of contact.
(4) additionally portion print and comparison print will the most uniformly inoculate 1.0ml bacteria suspension, be respectively put in sterilizing bottle envelope
After Kou, put in 20 DEG C of incubators immediately, take out after 24h, do viable bacteria according to step (3) and cultivate counting, try after detecting its contact 24h
Bacterium number on sample.
(5) according to below equation calculating result of the test:
Bacteriostasis rate (%)=×100
Wherein: A: the bacterium number on antibacterial sample after contact 24h
Bacterium number on B: " 0 " time of contact antibacterial sample.
Two, assay:
(1) embodiment of the present invention 1 antibiotic facing material is that 100%(is shown in the bacteriostasis rate of staphylococcus aureus ATCC6538 effect 24h
Table 1)
Table 1 antibiotic facing material fungistatic effect to golden yellow Portugal coccus ATCC6538 effect 24h
(2) embodiment of the present invention 1 antibiotic facing material acts on the bacteriostasis rate of 24h to escherichia coli 8099 is that 100%(is shown in Table 2)
Table 2 antibiotic facing material acts on the fungistatic effect of 24h to escherichia coli 8099
(3) embodiment of the present invention 1 antibiotic facing material is that 99.85%(is shown in Table to the bacteriostasis rate of Candida albicans ATCC10231 effect 24h
3).
Table 3 antibiotic facing material fungistatic effect to Candida albicans ATCC10231 effect 24h
Check conclusion:
(1) repeating test through 3 times to show, antibiotic facing material is 100% to the average inhibition of staphylococcus aureus effect 24h；
(2) repeating test through 3 times to show, antibiotic facing material is 100% to the average inhibition of escherichia coli effect 24h；
(3) repeating test through 3 times to show, antibiotic facing material is 99.85% to the average inhibition of Candida albicans effect 24h.
The antibiotic finishing method of the chitosan derivatives of 3 one kinds of Medical face fabrics of performing the operation of embodiment
Comprise the following steps:
(1) grey cloth is prepared
(2) singe
(3) grey cloth desizing, kiering, bleaching
(4) short steaming working solution is padded
(5) cropping clot
Above-mentioned (1)-(5) use the method for embodiment 1.
(6) dipping acid stain working solution
Carry out gained fabric padding acid stain working solution, drying, bake/evaporate, wash, soap, wash and dry；Described
Pad acid stain working solution, bath raio 1:35；
Described acid stain working solution, formula is acid stain 4 g/L, acetic acid 2 g/L, auxiliary agent 3g/L, pH are 5, liquid carrying rate
100%；
Described auxiliary agent, in parts by weight, including following components: 1-propyl group phosphoric acid cyclic anhydride 6 parts, caprolactam 7 parts, tea polyphenols 4 parts,
Saponin 3 parts, acetaminol 2 parts, trioctyl phosphate 3 parts, resin acid calcium 5 parts, linoleic acid 6 parts, Oleum Folium Artemisiae Argyi 4 parts, alkyl phenol
Polyoxyethylene ether 7 parts, dehydrated alcohol 4 parts.
Wherein:
O.w.f: dye dosage is typically with percent (o.w.f) expression to fibre weight.
Described dyestuff is that Shanghai Wan get Dye Co., Ltd produces；
(7) dipping chitosan derivative antibacterial finishing agent step
Fabric uses dipping chitosan derivative antibacterial finishing agent process, then preliminary drying, dry, bake,
Described dipping chitosan derivative antibacterial finishing agent, bath raio 1:25；
Described chitosan derivative antibacterial finishing agent, extracts including carboxymethyl chitosan 20 parts, Fructus Quisqualis extract 3 parts, Semen Torreyae
Thing 5 parts, Semen Coicis extract 4 parts, Concha Ostreae extract 6 parts, poly 5 parts, cyanuric acid three-glycidyl ester 3 parts, metatitanic acid
Ester 2 parts, Triammonium citrate 1 part, tea saponin 2 parts, ethyl sebacate 4 parts, penetrating agent OT 5 parts, cetene 3 parts, cedrol 2
Part, glyceryl monostearate 4 parts, dehydrated alcohol 8 parts.
The concentration of described chitosan derivative antibacterial finishing agent is 50g/L.
Described Fructus Quisqualis extract, the content of palm acid is 29.2%, stearic content is 9.1%, the containing of myristic acid
Amount is 4.5%；
Described Semen Torreyae extract, wheat protein content is 20%, and sterol content is 30%；
Described penetrating agent model is OT, and quality index is solid content >=50%；PH value (1% aqueous solution) is 5.0-7.0；Penetration
(1% aqueous solution)≤5s；
Described Semen Coicis extract, the content of coixenolide is 5%；
Described Concha Ostreae extract, oyster peptide content is 95%, described oyster peptide, and molecular weight is 5000 dalton；Particle diameter is 100 mesh；
The preparation method of described carboxymethyl chitosan, 15 parts of chitosans add in 50% (w/w) NaOH solution of 100 parts and alkalize,
Then adding 150 parts of isopropanol stirrings, speed of agitator is 400r/min, and the time is 10min, then drips monoxone, chloroacetic
Rate of addition is 0.5g/min, is stirred during dropping, and rotating speed is 800r/min, and chloroacetic total addition is 18 parts,
Reacting 2h at 60 DEG C, neutralize with acid, 70% methanol repeatedly washs, and is then dissolved in water, then with acetone precipitation, filters, use anhydrous second
Alcohol cyclic washing, filters, and vacuum drying obtains the carboxymethyl chitosan refined.
Described part is mass parts.
Described preliminary drying, temperature is 105 DEG C, and the time is 1.5min,
Described drying, temperature is 70 DEG C, and the time is 6min；
Described baking, temperature is 140 DEG C, and the time is 3.5min.
(8) rolling
The fabric put in order is carried out clot, prepares nature, biological antibacterial operation Medical face fabric.
The technique effect of fabric described in the embodiment of the present invention 3:
A, employing experimental technique described in embodiment 2, measure the anti-microbial property of fabric described in embodiment 3, and result is
Repeat test through 3 times to show, the average suppression to staphylococcus aureus effect 24h of the embodiment of the present invention 3 antibiotic facing material
Rate is 100%；
Repeating test through 3 times to show, the average inhibition of escherichia coli effect 24h is by the embodiment of the present invention 3 antibiotic facing material
100%；
Repeating test through 3 times to show, the average inhibition of Candida albicans effect 24h is by the embodiment of the present invention 3 antibiotic facing material
99.99%。
B, polysaccharid derivative antibacterial medical fabric embodiment 3 prepared are after washing through 100 high-temperature water, and the present invention is real
Executing example 3 antibiotic facing material to the average inhibition of staphylococcus aureus effect 24h is 99.3%；Escherichia coli effect 24h is put down
All suppression ratio are 99.5%；Average inhibition to Candida albicans effect 24h is 99.1%.
The fabric of C, the embodiment of the present invention 3 preparation, moisture permeability is good, and measure wicking height is 205mm, and vapor transfer rate is
13500g(m2, d), evaporation rate is 0.75g/h；Air permenbility reaches 12500g/m2/24hr。
The fabric of D, the embodiment of the present invention 3 preparation, has anlistatig effect, and surface charge density is 0.6 μ C/m2, half
The phase of declining is 0.16s.
The fabric of E, the embodiment of the present invention 3 preparation, also has the effect of anti-mite and mosquito proof, acarid is walked quickly and kept away rate and reaches
96%, mosquito is walked quickly and kept away rate and reaches 97%.
The composite material of F, the embodiment of the present invention 3 preparation, warp-wise ultimate strength is 1590N, and broadwise ultimate strength is 980N；
Warp-wise tearing brute force is 55N, and broadwise tearing brute force is 35.8N；After washing 100 times, warp-wise washing shrinkage is 0.5%, broadwise washing shrinkage
It is 0.4%；Color fastness to water (variable color) is 5 grades, and color fastness to water (staining) reaches 4 grades；Acidproof PERSPIRATION COLOR FASTNESS (variable color) reaches 5 grades,
Acidproof PERSPIRATION COLOR FASTNESS (staining) reaches 4 grades, and alkaline-resisting PERSPIRATION COLOR FASTNESS (variable color) reaches 5 grades, and alkaline-resisting PERSPIRATION COLOR FASTNESS (staining) reaches 4
Level, colour fastness to rubbing (dry friction) reaches 5 grades.
In dyeing and finishing technology, concentration is on the basis of fabric weight, the percentage ratio of opposed fabric；
Bath raio refers to the ratio of dip-dye mode fabric and dye liquor, also known as liquor ratio；Refer to the part by weight of textile and dye liquor.
Unless specifically indicated, ratio of the present invention, it is mass ratio, described percentage ratio, is mass percent.
Finally it is noted that the foregoing is only the preferred embodiments of the present invention, it is not limited to the present invention,
Although being described in detail the present invention with reference to previous embodiment, for a person skilled in the art, it still may be used
So that the technical scheme described in foregoing embodiments to be modified, or wherein portion of techniques feature is carried out equivalent.
All within the spirit and principles in the present invention, any modification, equivalent substitution and improvement etc. made, should be included in the present invention's
Within protection domain.
Claims (10)
1. the antibiotic finishing method of the chitosan derivatives of a Medical face fabric of performing the operation, it is characterised in that: include
Dipping acid stain working solution, dipping chitosan derivative antibacterial finishing agent step.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 1, its feature
Being: described acid stain working solution, the concentration of each composition is: acid stain 2-7g/L, acetic acid 5-8 g/L, levelling agent 0.3-1
G/L, color fixing agent 3-5 g/L；Described acid stain working solution, pH 4-6, liquid carrying rate 100%.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 1, its feature
It is: described dipping acid stain working solution, dipping temperature is 45-60 DEG C.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 2, its feature
Being: described acid stain working solution, the concentration of each composition is, preferably acid stain 2g/L, acetic acid 5 g/L, levelling agent 0.5
G/L, color fixing agent 5 g/L.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 1, its feature
It is: described chitosan derivative antibacterial finishing agent, including antibacterial finishing agent O-HTCCS 0.5-5g/L, cross-linking agent 4-20g/L,
Catalyst 6-9g/L, penetrating agent 2-5g/L.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 5, its feature
It is: described dipping chitosan derivative antibacterial finishing agent, bath raio 1:20.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 5, its feature
Being: described cross-linking agent, model is DTF-31；Described catalyst, model is CQL-5；Described penetrating agent, model is JFC.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 5, its feature
Being: described dipping chitosan derivative antibacterial finishing agent, detailed process is: first impregnated crosslinked dose and catalyst, and two leachings two are rolled,
Liquid carrying rate 100%, after 80 DEG C dry 3 minutes, dipping penetrating agent, liquid carrying rate 100%, then dipping antibacterial finishing agent O-HTCCS, two
Leaching two is rolled, liquid carrying rate 100%, after 80 DEG C dry 3 minutes, 105 DEG C of preliminary drying 2min, 120-160 DEG C bake 1-3min, washing, 80 DEG C
Dry 3min.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 1, its feature
Being: described acid stain working solution, formula is acid stain 4 g/L, acetic acid 2 g/L, auxiliary agent 3g/L；Described auxiliary agent, with weight
Amount part meter, including following components: 1-propyl group phosphoric acid cyclic anhydride 6 parts, caprolactam 7 parts, tea polyphenols 4 parts, saponin 3 parts, acetaminol 2
Part, trioctyl phosphate 3 parts, resin acid calcium 5 parts, linoleic acid 6 parts, Oleum Folium Artemisiae Argyi 4 parts, alkylphenol polyoxyethylene 7 parts, anhydrous
Ethanol 4 parts.
The antibiotic finishing method of the chitosan derivatives of a kind of Medical face fabric of performing the operation the most according to claim 1, its feature
It is: described chitosan derivative antibacterial finishing agent, extracts including carboxymethyl chitosan 20 parts, Fructus Quisqualis extract 3 parts, Semen Torreyae
Thing 5 parts, Semen Coicis extract 4 parts, Concha Ostreae extract 6 parts, poly 5 parts, cyanuric acid three-glycidyl ester 3 parts, metatitanic acid
Ester 2 parts, Triammonium citrate 1 part, tea saponin 2 parts, ethyl sebacate 4 parts, penetrating agent OT 5 parts, cetene 3 parts, cedrol 2
Part, glyceryl monostearate 4 parts, dehydrated alcohol 8 parts；The concentration of described chitosan derivative antibacterial finishing agent is 50g/L.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610502434.0A CN106012513A (en) | 2016-06-30 | 2016-06-30 | Antibacterial finishing method of chitosan derivative of medical fabric for surgeries |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610502434.0A CN106012513A (en) | 2016-06-30 | 2016-06-30 | Antibacterial finishing method of chitosan derivative of medical fabric for surgeries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106012513A true CN106012513A (en) | 2016-10-12 |
Family
ID=57104823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610502434.0A Pending CN106012513A (en) | 2016-06-30 | 2016-06-30 | Antibacterial finishing method of chitosan derivative of medical fabric for surgeries |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106012513A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103290704A (en) * | 2013-04-23 | 2013-09-11 | 太仓市其盛化纤厂 | Components of colorant composition |
| CN103882689A (en) * | 2012-12-20 | 2014-06-25 | 青岛同冠王实业有限公司 | Method for processing cotton fabric by chitosan derivative |
| CN105002730A (en) * | 2015-08-14 | 2015-10-28 | 太仓天龙化纤有限公司 | Low-temperature dyeing and finishing technology of cottonette |
-
2016
- 2016-06-30 CN CN201610502434.0A patent/CN106012513A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103882689A (en) * | 2012-12-20 | 2014-06-25 | 青岛同冠王实业有限公司 | Method for processing cotton fabric by chitosan derivative |
| CN103290704A (en) * | 2013-04-23 | 2013-09-11 | 太仓市其盛化纤厂 | Components of colorant composition |
| CN105002730A (en) * | 2015-08-14 | 2015-10-28 | 太仓天龙化纤有限公司 | Low-temperature dyeing and finishing technology of cottonette |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105177985B (en) | A kind of preparation method, cotton fabric and its application of anti-bacteria and anti-virus cotton fabric | |
| CN105239389B (en) | A kind of dedicated antibacterial textile fabric of baby | |
| CN103147288B (en) | Method for preparing halamine antibacterial material based on cyanuric chloride | |
| CN101760963B (en) | Antibiotic-mould proof textile fabric and method for preparing same | |
| CN107177925A (en) | Antibiosis anti-acarien underwear fabric and its finishing technique | |
| CN105155278A (en) | Anti-crease finishing liquid and anti-crease finishing method for real silk shell fabric | |
| CN106120329A (en) | A kind of antistatic, fire-retardant, the production technology of water and oil repellant anti-soil Multifunctional composite fabric | |
| CN106757494A (en) | A kind of pro-skin antibiotic facing material and its processing method | |
| JP2010090523A (en) | Antibacterial deodorization-bacteriostatic processing method for fibrous structure | |
| CN106012092B (en) | A kind of multifunctional protein fiber and preparation method thereof | |
| CN109457466A (en) | Functionalized carbon nano-tube and its application in antistatic antibiotic fabric finishing liquor | |
| CN109295711A (en) | A kind of preparation method and fibre of the antiviral anti-bacterial fibre of water-fastness type | |
| CN102041682A (en) | Anti-bacteria and anti-influenza virus functional fabric and preparation method thereof | |
| CN104213401B (en) | A kind of anti-blood, anti-alcohol, antimicrobial Medical protective fabric and preparation method thereof | |
| CN106592056B (en) | A kind of processing method of waterproof insulating fabric | |
| JPH0813341A (en) | Method for processing cellulosic fabric | |
| CN106637950A (en) | Finishing agent having function of reinforcing air permeability of textiles and preparation method of finishing agent | |
| CN104358136B (en) | A kind of modified eider down and preparation method thereof | |
| CN106592055B (en) | A kind of processing method of ultraviolet-resistant fabric | |
| CN106012513A (en) | Antibacterial finishing method of chitosan derivative of medical fabric for surgeries | |
| CN106087387A (en) | A kind of antibacterial composite fabric containing traditional Chinese medicine extraction component | |
| CN110205812A (en) | A kind of warming quick dried environment protection cloth setting process | |
| CN111235883B (en) | Anti-wrinkle modified cotton fiber and preparation method thereof | |
| US20180051412A1 (en) | Specialty fabrics having anti-microbial, stain release, and dust resistant properties | |
| CN108411616A (en) | A kind of crease-resistant mite-assistant fabrics method for sorting |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |
|
| RJ01 | Rejection of invention patent application after publication |